Use cases
Use cases
Knowledge Graphs
Build better knowledge graphs with millions of novel high quality cause-and-effect relationships and contextual data
MoA & Explainability
Novel evidence to explain diseases and hypothesise treatment approaches
Biomarker Selection
Identify novel pharmacodynamic biomarkers from > 40 million documents
Target Selection
Infer drug-target-disease cause-and-effect relationships to ID novel targets and validate existing hypotheses
Indication Expansion
Use data annotations to identify diseases directly connected to a target based on well-established literature evidence
Knowledge Reviews
Systematically retrieve all relevant information to support go/no-go decisions
Solutions
Solutions
Data scientists
The most novel knowledge graph of rich, unique data
Biologists
Novel targets and never-before-seen biological research evidence
Information Managers
The forefront of federated architecture and GenAI
Company
Resources
Resources
News
Insights and blog posts
Events
Upcoming conferences
Downloads
Datasheets and other resources
Webinars
Live events and recordings
Knowledge Graphs in Drug Discovery
Virtual conference series
Galactic Web login
Request demo
Galactic Web login
Request demo
News
Super models: A framework to optimise R&D success with AI, PharmaTimes
Super models: A framework to optimise R&D success with AI, PharmaTimes
Dr Ben Sidders, Chief Scientific Officer at Biorelate
February 27, 2025
•
5 min read
Share this post
Biorelate News
Latest News
Discover new insights and updates for data science in biopharma
View all
The promise of AI for addressing pressing drug discovery inefficiencies, according to large pharma experts
In this blog post, we dive into the insights shared by pharma experts on the promise AI holds for addressing these challenges.
Unlocking the Future of Precision Oncology with Knowledge Graphs
A recent study published in Journal of Translational Medicine illustrates how the integration of knowledge graph-driven insights into survival prediction and biomarker discovery paves the way for more precise personalised cancer treatments.
The importance of data quality in 2025, according to pharma leaders
3 key areas of data quality in AI are captured by pharma leaders at the recent Festival of Genomics conference: biases in data, incorporation of multimodal datasets and availability of patient-specific data.
View all
